Activation of mouse liver natural killer cells and NK1.1+ T cells by bacterial superantigen-primed Kupffer cells

Hepatology

Volumn 30, Issue 2, 1999, Pages 430-436

  Dobashi, Hiroshi ^a   Seki, Shuhji ^a   Habu, Yoshiko ^a   Ohkawa, Takashi ^a   Takeshita, Seiichiro ^a   Hiraide, Hoshio ^a   Sekine, Isao ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; STAPHYLOCOCCUS ENTEROTOXIN B; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CYTOTOXICITY; FLOW CYTOMETRY; INTERFERON PRODUCTION; KUPFFER CELL; MALE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIGENS; ANTIGENS, SURFACE; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ENTEROTOXINS; EXOTOXINS; FLOW CYTOMETRY; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; KUPFFER CELLS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PROTEINS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0032811762     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300209     Document Type: Article

References (17)

1. Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 1993;9:101-128.
2. Paris AL, Herwaldt LA, Blum D, Schmid GP, Shands KN, Broome CV. Pathogenic findings in twelve fatal cases of toxic shock syndrome. Ann Intern Med 1982;96:852-857.
3. Larkin SM, Williams DN, Osterholm MT, Tofte LW, Posalaky Z. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann Intern Med 1982;96:858-864.
4. Parsonnet J, Gillis ZA, Richter AG, Pier GB. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun 1987;55:1070-1076.
5. Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:811-813.
6. + αβT cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
7. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996;156:3366-3373.
8. + T cells and their IFN-γ production in the generalized Shwartzman reaction. J Immunol 1998;160: 3522-3527.
9. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996;156:2436-2442.
10. Kamezawa Y, Nakahara T. Purification and characterization of streptococcal erythrogenic toxin type A produced by Streptococcus pyogenes strain NY-5 cultured in the synthetic medium NCTC-135. Comparison with the dialyzed medium (TP medium)-derived toxin. Microbiol Immunol 1989;33:183-194.
11. Kawachi Y, Arai K, Moroda T, Kawamura T, Umezu H, Naito M, Ohtsuka K, et al. Supportive elements for hepatic T cell differentiation: T cell expressing intermediate levels of the T cell receptor are cytotoxic against syngeneic hepatoma, and are lost after hepatocyte damage. Eur J Immunol 1995;25:3452-3459.
12. Watanabe T, Kawamura T, Kawamura H, Haga M, Shirai K, Watanabe H, Eguchi S, et al. Intermediate TCR cells in the lung. Their effector function to induce pneumonitis in mice with autoimmune-like graft-versus-host disease. J Immunol 1997;158:5805-5814.
13. Tsukahara A, Seki S, Iiai T, Moroda T, Watanabe H, Suzuki S, Tada T, et al. Mouse liver T cells: Their change with aging and in comparison with peripheral T cells. HEPATOLOGY 1997;26:301-309.
14. Nishimura T, Ito T. Higher level expression of lymphocyte function-associate antigen-1 (LFA-1) on in vivo natural killer cells. Eur J Immunol 1988;18:2077-2088.
15. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci U S A 1992;89:4066-4070.
16. Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Childh 1995;72:308-311.
17. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-329.